Peer-reviewed articles

Sharkey Ochoa I, O’Regan E, Toner M, et al. The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2022;14(17). doi:10.3390/cancers14174321

Di Carlo V, Stiller CA, Eisemann N, et al. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000–2014 in 59 countries (CONCORD-3). British Journal of Dermatology. 2022;187(3):364-380. doi:10.1111/bjd.21274

Cardoso R, Guo F, Heisser T, et al. Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study. Lancet Gastroenterol Hepatol. 2022;7(8):711-723. doi:10.1016/S2468-1253(22)00084-X

Arnold M, Morgan E, Bardot A, et al. International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study). Gut. 2022;71(8):1532-1543. doi:10.1136/gutjnl-2021-325266

Vener C, Rossi S, Minicozzi P, et al. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials. Front Oncol. 2022;12:892684. doi:10.3389/fonc.2022.892684

Ssenyonga N, Stiller C, Nakata K, et al. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. The Lancet Child & Adolescent Health. 2022;6(6):409-431. doi:10.1016/S2352-4642(22)00095-5

Sexton GP, Walsh P, Moriarty F, O’Neill JP. The changing face of Irish head and neck cancer epidemiology: 20 years of data. Eur Arch Otorhinolaryngol. 2022;279(6):3079-3088. doi:10.1007/s00405-021-07118-4

Menzies S, O’Leary E, Callaghan G, et al. A population-based comparison of organ transplant recipients in whom cutaneous squamous cell develops versus those in whom basal cell carcinoma develops. J Am Acad Dermatol. 2022;86(6):1377-1379. doi:10.1016/j.jaad.2021.05.032

Anderson S, Breen KJ, Davis NF, Deady S, Sweeney P. Penile cancer in Ireland - A national review. Surgeon. 2022;20(3):187-193. doi:10.1016/j.surge.2021.04.004

Kelly M, O’Brien KM, Hannigan A. Specialist palliative cancer care in acute hospitals and place of death: a population study. BMJ Support Palliat Care. 2022;12(e1):e94-e102. doi:10.1136/bmjspcare-2020-002232

O’Connell E, McDevitt J, Hill ADK, McNamara DA, Burke JP. Centralisation of rectal cancer care has improved patient survival in the republic of Ireland. Eur J Surg Oncol. 2022;48(4):890-895. doi:10.1016/j.ejso.2021.10.031

Araghi M, Fidler-Benaoudia M, Arnold M, et al. International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study. Thorax. 2022;77(4):378-390. doi:10.1136/thoraxjnl-2020-216555

Molcho M, Thomas AA, Walsh PM, Skinner R, Sharp L. Social inequalities in treatment receipt for childhood cancers in Ireland: A population-based analysis. Int J Cancer. 2022;150(6):941-951. doi:10.1002/ijc.33856

Keeling E, O’Leary E, Deady S, O Neill JP, Conlon PJ, Moloney FJ. Gender and immunosuppression impact on Merkel cell carcinoma diagnosis and prognosis. A population based cohort study. Skin Health Dis. 2022;2(1):e80. doi:10.1002/ski2.80

Clarke N, Dunne S, Coffey L, et al. Health literacy impacts self-management, quality of life and fear of recurrence in head and neck cancer survivors. J Cancer Surviv. 2021;15(6):855-865. doi:10.1007/s11764-020-00978-5

Rosato V, Gómez-Rubio P, Molina-Montes E, et al. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study. Eur J Cancer Prev. 2021;30(6):423-430. doi:10.1097/CEJ.0000000000000588

Girardi F, Rous B, Stiller CA, et al. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3). Neuro-Oncology. 2021;23(10):1765-1776. doi:10.1093/neuonc/noab067

Morgan E, Arnold M, Rutherford MJ, et al. The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project). Int J Cancer. 2021;149(5):1013-1020. doi:10.1002/ijc.33620

O’Connor M, Céilleachair AÓ, O’Brien K, et al. Health-related quality of life in women after colposcopy: results from a longitudinal patient survey. Qual Life Res. 2021;30(9):2509-2520. doi:10.1007/s11136-021-02831-3

Prior L, O’Dwyer R, Farooq AR, et al. Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study. Breast Cancer Res Treat. 2021;189(1):269-283. doi:10.1007/s10549-021-06263-y

Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021;22(7):1002-1013. doi:10.1016/S1470-2045(21)00199-6

Pilleron S, Charvat H, Araghi M, et al. Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. Int J Cancer. 2021;148(7):1575-1585. doi:10.1002/ijc.33326

Andersson TML, Myklebust TÅ, Rutherford MJ, et al. The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study. Cancer Epidemiol. 2021;71(Pt A):101881. doi:10.1016/j.canep.2020.101881

López de Maturana E, Rodríguez JA, Alonso L, et al. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Genome Med. 2021;13(1):15. doi:10.1186/s13073-020-00816-4

Morgan E, Soerjomataram I, Gavin AT, et al. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut. 2021;70(2):234-242. doi:10.1136/gutjnl-2020-321089